Pharmaceutical Technology, Nov 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Pharmaceutical Technology, Nov 1, 2010
Online Exclusives
Drug Targeting by Diagnostic Ultrasound Contrast
By Steliyan Tinkov , Conrad Coester , Raffi Bekeredjian , Gerhard Winter
Microbubbles can temporarily open many biological barriers for polar molecules, macromolecules, and particles. Scientists have brought well-known contrast agents back to the laboratory and redesigned them as drug carriers. This article is part of a special Drug Delivery issue.
Articles
Sustained-Release Injectable Drug Delivery
By Yun-Seok Rhee , Chun-Woong Park , Patrick P. DeLuca , Heidi M. Mansour
A review on the current status of long-acting injectables, including commercially marketed products. This article is part of a special Drug Delivery issue.
Transdermal Delivery of Vaccines and Therapeutic Proteins
By Kris J. Hansen
The author reviews advances in technology that may soon allow transdermal delivery of two of the fastest growing drug classes on the pharmaceutical market. This article is part of a special Drug Delivery issue.
Considerations and Approaches for Filling Dry-Powder Inhalers
By Craig J. Davies Cutting
The author reviews key considerations for formulating powders for use in inhalers. This article is part of a special Drug Delivery issue.
Capsule-in-Capsule Technology
By W.J. Bowtle
The author outlines how to choose carriers and capsule shells according to dosage requirements and intended use. This article is part of a special Drug Delivery issue.
Melt Extrusion: Shaping Drug Delivery in the 21st Century
By James C. DiNunzio , Charlie Martin , Feng Zhang
The authors provde a review of melt extrusion's evolution and applications in the pharmaceutical industry. This article is part of a special Drug Delivery issue.
Minitablets Coated in a Solid-Wall Pan for Theophylline Sustained-Release Capsules
By Caterina Funaro , Giusi Mondelli , Nadia Passerini , Beatrice Albertini
The authors describe an alternative approach to compressing and coating minitablets for use in a sustained-release, solid oral-dosage form. This article is part of a special Drug Delivery issue.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here